The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products.


Updates from The Motley Fool

Latest updates on Allergan from Fool.com.  The Fool has written over 200 articles on Allergan.
3 Dividend Healthcare Stocks

If you're on the hunt for outstanding healthcare dividend stocks, Allergan, Bristol-Myers Squibb,...

3 Dividend Healthcare Stocks

Looking for income from the healthcare sector? Here's why you should check out Gilead Sciences, A...



Stock Performance

View Interactive AGN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Allergan.
Current Price: $174.83
Prev Close: $170.67
Open: $171.00
Bid: $0.00
Ask: $0.00
Day's Range: $170.15 - $176.08
52wk Range: $169.61 - $256.80
Volume: 2,856,367
Avg Vol 4,710,076
Market Cap: $58B
P/E (ttm): -7.74
EPS (ttm): ($22.59)
Div & Yield: $2.80 (1.6%)

Company Rating

What our community thinks about Allergan.
CAPS Rating 4 out of 5
 
417 Outperform
30 Underperform
CAPS All Stars
 
102 Outperform
7 Underperform

How do you think Allergan will perform against the market?



You pick for Allergan is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Brenton L. Saunders, CEO

69% Approve

Based on 161 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Allergan.

The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers